These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9081560)

  • 21. Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome.
    Cutler NR
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):309-21. PubMed ID: 2948218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.
    Minoshima S; Giordani B; Berent S; Frey KA; Foster NL; Kuhl DE
    Ann Neurol; 1997 Jul; 42(1):85-94. PubMed ID: 9225689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated cerebellar glucose metabolism in microvascular white matter disease: normal aging and Alzheimer's disease.
    Klinger A; de Leon MJ; George AE; Miller JD; Wolf AP
    J Cereb Blood Flow Metab; 1988 Jun; 8(3):433-5. PubMed ID: 3259243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.
    Sultzer DL; Mahler ME; Mandelkern MA; Cummings JL; Van Gorp WG; Hinkin CH; Berisford MA
    J Neuropsychiatry Clin Neurosci; 1995; 7(4):476-84. PubMed ID: 8555751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional hypometabolism related to language disturbance in Alzheimer's disease.
    Hirono N; Mori E; Ishii K; Ikejiri Y; Imamura T; Shimomura T; Ikeda M; Yamashita H; Takatsuki Y; Sasaki M
    Dement Geriatr Cogn Disord; 1998; 9(2):68-73. PubMed ID: 9524796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of piracetam on cerebral glucose metabolism in Alzheimer's disease as measured by positron emission tomography.
    Heiss WD; Hebold I; Klinkhammer P; Ziffling P; Szelies B; Pawlik G; Herholz K
    J Cereb Blood Flow Metab; 1988 Aug; 8(4):613-7. PubMed ID: 3260597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
    Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D
    N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.
    Koss E; Friedland RP; Ober BA; Jagust WJ
    Am J Psychiatry; 1985 May; 142(5):638-40. PubMed ID: 3872604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive impairment in Alzheimer's disease correlates with ventricular width and atrophy-corrected cortical glucose metabolism.
    Slansky I; Herholz K; Pietrzyk U; Kessler J; Grond M; Mielke R; Heiss WD
    Neuroradiology; 1995 May; 37(4):270-7. PubMed ID: 7666958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications.
    Smith GS; de Leon MJ; George AE; Kluger A; Volkow ND; McRae T; Golomb J; Ferris SH; Reisberg B; Ciaravino J
    Arch Neurol; 1992 Nov; 49(11):1142-50. PubMed ID: 1444881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards a behavioral typology of Alzheimer's patients.
    Martin A; Brouwers P; Lalonde F; Cox C; Teleska P; Fedio P; Foster NL; Chase TN
    J Clin Exp Neuropsychol; 1986 Oct; 8(5):594-610. PubMed ID: 3492510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diminished glucose transport in Alzheimer's disease: dynamic PET studies.
    Jagust WJ; Seab JP; Huesman RH; Valk PE; Mathis CA; Reed BR; Coxson PG; Budinger TF
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):323-30. PubMed ID: 1997504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18.
    Zahn R; Juengling F; Bubrowski P; Jost E; Dykierek P; Talazko J; Huell M
    Psychiatry Res; 2004 Dec; 132(2):159-72. PubMed ID: 15598550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NIH Conference. Brain imaging: aging and dementia.
    Cutler NR; Duara R; Creasey H; Grady CL; Haxby JV; Schapiro MB; Rapoport SI
    Ann Intern Med; 1984 Sep; 101(3):355-69. PubMed ID: 6235763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography.
    Foster NL; VanDerSpek AF; Aldrich MS; Berent S; Hichwa RH; Sackellares JC; Gilman S; Agranoff BW
    J Cereb Blood Flow Metab; 1987 Aug; 7(4):415-20. PubMed ID: 3497161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
    Alavi A; Newberg AB; Souder E; Berlin JA
    J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease.
    Berent S; Giordani B; Foster N; Minoshima S; Lajiness-O'Neill R; Koeppe R; Kuhl DE
    J Psychiatr Res; 1999; 33(1):7-16. PubMed ID: 10094234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
    Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
    JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron emission tomographic study in Alzheimer's disease and Pick's disease.
    Salmon E; Franck G
    Arch Gerontol Geriatr Suppl; 1989; 1():241-7. PubMed ID: 2787995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral glucose metabolic patterns in Alzheimer's disease. Effect of gender and age at dementia onset.
    Small GW; Kuhl DE; Riege WH; Fujikawa DG; Ashford JW; Metter EJ; Mazziotta JC
    Arch Gen Psychiatry; 1989 Jun; 46(6):527-32. PubMed ID: 2730277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.